How should a foot ulcer with meropenem-resistant and carbapenem-resistant organisms be managed according to current guidelines?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18115290
Cited by: 0

Abstract

For diabetic foot ulcers with meropenem and carbapenem-resistant organisms, management involves tailored antibiotic therapy guided by culture and susceptibility, specialist consultation, and a multidisciplinary approach.

Fields of Study & Subjects

Diabetic Foot Ulcer Assessment and Management Orthopedic Infections and Treatments Antimicrobial Resistance in Staphylococcus

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
1 January 2026